APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Preventable Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pediatric Preventable Vaccine Industry Research Report 2026

26 December 2025131 pages

Choose your research edition.

Industry ResearchPediatric Preventable Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Preventable Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pediatric Preventable Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Preventable Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Preventable Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pediatric Preventable Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pediatric Preventable Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pediatric Preventable Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pediatric Preventable Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pediatric Preventable Vaccine include Sanofi Pasteur, Johnson & Johnson (Janssen), Pfizer Inc., GlaxoSmithKline plc (GSK), Sinovac Biotech, Sinopharm Group Co.,, Serum Institute of India Pvt., Novavax, Inc. and Moderna, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pediatric Preventable Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pediatric Preventable Vaccine Market by Company

Sanofi Pasteur

Johnson & Johnson (Janssen)

Pfizer Inc.

GlaxoSmithKline plc (GSK)

Sinovac Biotech

Sinopharm Group Co.,

Serum Institute of India Pvt.

Novavax, Inc.

Moderna, Inc.

Merck & Co., Inc.

Emergent BioSolutions Inc.

Daiichi Sankyo Company

CSL Limited (Seqirus)

Bharat Biotech International

AstraZeneca plc

Pediatric Preventable Vaccine Segment by Type

Subunit Vaccines

Inactivated Vaccines

Live Vaccines

Viral Vector Vaccines

Mrna Vaccines

Pediatric Preventable Vaccine Segment by Application

Bacterial Diseases

Virus Diseases

Pediatric Preventable Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Preventable Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Preventable Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Preventable Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pediatric Preventable Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pediatric Preventable Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pediatric Preventable Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pediatric Preventable Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pediatric Preventable Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pediatric Preventable Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pediatric Preventable Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Pediatric Preventable Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pediatric Preventable Vaccine, Product Type & Application Table 14. Global Pediatric Preventable Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pediatric Preventable Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sanofi Pasteur Company Information Table 19. Sanofi Pasteur Business Overview Table 20. Sanofi Pasteur Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Sanofi Pasteur Pediatric Preventable Vaccine Product Portfolio Table 22. Sanofi Pasteur Recent Developments Table 23. Johnson & Johnson (Janssen) Company Information Table 24. Johnson & Johnson (Janssen) Business Overview Table 25. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product Portfolio Table 27. Johnson & Johnson (Janssen) Recent Developments Table 28. Pfizer Inc. Company Information Table 29. Pfizer Inc. Business Overview Table 30. Pfizer Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Pfizer Inc. Pediatric Preventable Vaccine Product Portfolio Table 32. Pfizer Inc. Recent Developments Table 33. GlaxoSmithKline plc (GSK) Company Information Table 34. GlaxoSmithKline plc (GSK) Business Overview Table 35. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Portfolio Table 37. GlaxoSmithKline plc (GSK) Recent Developments Table 38. Sinovac Biotech Company Information Table 39. Sinovac Biotech Business Overview Table 40. Sinovac Biotech Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sinovac Biotech Pediatric Preventable Vaccine Product Portfolio Table 42. Sinovac Biotech Recent Developments Table 43. Sinopharm Group Co., Company Information Table 44. Sinopharm Group Co., Business Overview Table 45. Sinopharm Group Co., Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Sinopharm Group Co., Pediatric Preventable Vaccine Product Portfolio Table 47. Sinopharm Group Co., Recent Developments Table 48. Serum Institute of India Pvt. Company Information Table 49. Serum Institute of India Pvt. Business Overview Table 50. Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Portfolio Table 52. Serum Institute of India Pvt. Recent Developments Table 53. Novavax, Inc. Company Information Table 54. Novavax, Inc. Business Overview Table 55. Novavax, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Novavax, Inc. Pediatric Preventable Vaccine Product Portfolio Table 57. Novavax, Inc. Recent Developments Table 58. Moderna, Inc. Company Information Table 59. Moderna, Inc. Business Overview Table 60. Moderna, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Moderna, Inc. Pediatric Preventable Vaccine Product Portfolio Table 62. Moderna, Inc. Recent Developments Table 63. Merck & Co., Inc. Company Information Table 64. Merck & Co., Inc. Business Overview Table 65. Merck & Co., Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Merck & Co., Inc. Pediatric Preventable Vaccine Product Portfolio Table 67. Merck & Co., Inc. Recent Developments Table 68. Emergent BioSolutions Inc. Company Information Table 69. Emergent BioSolutions Inc. Business Overview Table 70. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Portfolio Table 72. Emergent BioSolutions Inc. Recent Developments Table 73. Daiichi Sankyo Company Company Information Table 74. Daiichi Sankyo Company Business Overview Table 75. Daiichi Sankyo Company Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Daiichi Sankyo Company Pediatric Preventable Vaccine Product Portfolio Table 77. Daiichi Sankyo Company Recent Developments Table 78. CSL Limited (Seqirus) Company Information Table 79. CSL Limited (Seqirus) Business Overview Table 80. CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Portfolio Table 82. CSL Limited (Seqirus) Recent Developments Table 83. Bharat Biotech International Company Information Table 84. Bharat Biotech International Business Overview Table 85. Bharat Biotech International Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bharat Biotech International Pediatric Preventable Vaccine Product Portfolio Table 87. Bharat Biotech International Recent Developments Table 88. AstraZeneca plc Company Information Table 89. AstraZeneca plc Business Overview Table 90. AstraZeneca plc Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AstraZeneca plc Pediatric Preventable Vaccine Product Portfolio Table 92. AstraZeneca plc Recent Developments Table 93. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Pediatric Preventable Vaccine Sales by Region (2021-2026) & (K Units) Table 95. Global Pediatric Preventable Vaccine Sales Market Share by Region (2021-2026) Table 96. Global Pediatric Preventable Vaccine Sales by Region (2027-2032) & (K Units) Table 97. Global Pediatric Preventable Vaccine Sales Market Share by Region (2027-2032) Table 98. Global Pediatric Preventable Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2021-2026) Table 100. Global Pediatric Preventable Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2027-2032) Table 102. North America Pediatric Preventable Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 104. North America Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 105. North America Pediatric Preventable Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Pediatric Preventable Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Pediatric Preventable Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 109. Europe Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 110. Europe Pediatric Preventable Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Pediatric Preventable Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Pediatric Preventable Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Pediatric Preventable Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Pediatric Preventable Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Pediatric Preventable Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 119. South America Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 120. South America Pediatric Preventable Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Pediatric Preventable Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Pediatric Preventable Vaccine Sales by Type (2021-2026) & (K Units) Table 128. Global Pediatric Preventable Vaccine Sales by Type (2027-2032) & (K Units) Table 129. Global Pediatric Preventable Vaccine Sales Market Share by Type (2021-2026) Table 130. Global Pediatric Preventable Vaccine Sales Market Share by Type (2027-2032) Table 131. Global Pediatric Preventable Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Pediatric Preventable Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021-2026) Table 134. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2027-2032) Table 135. Global Pediatric Preventable Vaccine Price by Type (2021-2026) & (US$/Unit) Table 136. Global Pediatric Preventable Vaccine Price by Type (2027-2032) & (US$/Unit) Table 137. Global Pediatric Preventable Vaccine Sales by Application (2021-2026) & (K Units) Table 138. Global Pediatric Preventable Vaccine Sales by Application (2027-2032) & (K Units) Table 139. Global Pediatric Preventable Vaccine Sales Market Share by Application (2021-2026) Table 140. Global Pediatric Preventable Vaccine Sales Market Share by Application (2027-2032) Table 141. Global Pediatric Preventable Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Pediatric Preventable Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021-2026) Table 144. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2027-2032) Table 145. Global Pediatric Preventable Vaccine Price by Application (2021-2026) & (US$/Unit) Table 146. Global Pediatric Preventable Vaccine Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Pediatric Preventable Vaccine Distributors List Table 150. Pediatric Preventable Vaccine Customers List Table 151. Pediatric Preventable Vaccine Industry Trends Table 152. Pediatric Preventable Vaccine Industry Drivers Table 153. Pediatric Preventable Vaccine Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pediatric Preventable Vaccine Product Image Figure 5. Global Pediatric Preventable Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pediatric Preventable Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Pediatric Preventable Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Pediatric Preventable Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. Subunit Vaccines Product Image Figure 10. Inactivated Vaccines Product Image Figure 11. Live Vaccines Product Image Figure 12. Viral Vector Vaccines Product Image Figure 13. Mrna Vaccines Product Image Figure 14. Bacterial Diseases Product Image Figure 15. Virus Diseases Product Image Figure 16. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Pediatric Preventable Vaccine Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Pediatric Preventable Vaccine Sales by Region in 2025 Figure 22. Global Pediatric Preventable Vaccine Revenue by Region in 2025 Figure 23. North America Pediatric Preventable Vaccine Market Size by Country in 2025 Figure 24. North America Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 25. North America Pediatric Preventable Vaccine Revenue Market Share by Country (2021-2032) Figure 26. United States Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Pediatric Preventable Vaccine Market Size by Country in 2025 Figure 30. Europe Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 31. Europe Pediatric Preventable Vaccine Revenue Market Share by Country (2021-2032) Figure 32. Germany Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Pediatric Preventable Vaccine Market Size by Country in 2025 Figure 43. Asia Pacific Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Pediatric Preventable Vaccine Revenue Market Share by Country (2021-2032) Figure 45. China Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Pediatric Preventable Vaccine Market Size by Country in 2025 Figure 54. South America Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 55. South America Pediatric Preventable Vaccine Revenue Market Share by Country (2021-2032) Figure 56. Brazil Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Colombia Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Pediatric Preventable Vaccine Market Size by Country in 2025 Figure 61. Middle East and Africa Pediatric Preventable Vaccine Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Pediatric Preventable Vaccine Revenue Market Share by Country (2021-2032) Figure 63. Egypt Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Pediatric Preventable Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Pediatric Preventable Vaccine Sales Market Share by Type (2021-2032) Figure 69. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021-2032) Figure 70. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2021-2032) Figure 71. Global Pediatric Preventable Vaccine Sales Market Share by Application (2021-2032) Figure 72. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021-2032) Figure 73. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2021-2032) Figure 74. Pediatric Preventable Vaccine Value Chain Figure 75. Pediatric Preventable Vaccine Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Pediatric Preventable Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Subunit Vaccines
  • Inactivated Vaccines
  • Live Vaccines
  • Viral Vector Vaccines
  • Mrna Vaccines
Applications
  • Bacterial Diseases
  • Virus Diseases
Companies covered
  • Sanofi Pasteur
  • Johnson & Johnson (Janssen)
  • Pfizer Inc.
  • GlaxoSmithKline plc (GSK)
  • Sinovac Biotech
  • Sinopharm Group Co.,
  • Serum Institute of India Pvt.
  • Novavax, Inc.
  • Moderna, Inc.
  • Merck & Co., Inc.
  • Emergent BioSolutions Inc.
  • Daiichi Sankyo Company
  • CSL Limited (Seqirus)
  • Bharat Biotech International
  • AstraZeneca plc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pediatric Preventable Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Pediatric Preventable Vaccine Sales (2021-2032)
  5. 2.2.3 Global Pediatric Preventable Vaccine Market Average Price (2021-2032)
  6. 2.3 Pediatric Preventable Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Subunit Vaccines
  9. 2.3.3 Inactivated Vaccines
  10. 2.3.4 Live Vaccines
  11. 2.3.5 Viral Vector Vaccines
  12. 2.3.6 Mrna Vaccines
  13. 2.4 Pediatric Preventable Vaccine by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Bacterial Diseases
  16. 2.4.3 Virus Diseases
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pediatric Preventable Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pediatric Preventable Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Pediatric Preventable Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pediatric Preventable Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pediatric Preventable Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pediatric Preventable Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Pediatric Preventable Vaccine, Established Date
  9. 3.9 Global Pediatric Preventable Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sanofi Pasteur
  2. 4.1.1 Sanofi Pasteur Company Information
  3. 4.1.2 Sanofi Pasteur Business Overview
  4. 4.1.3 Sanofi Pasteur Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sanofi Pasteur Pediatric Preventable Vaccine Product Portfolio
  6. 4.1.5 Sanofi Pasteur Recent Developments
  7. 4.2 Johnson & Johnson (Janssen)
  8. 4.2.1 Johnson & Johnson (Janssen) Company Information
  9. 4.2.2 Johnson & Johnson (Janssen) Business Overview
  10. 4.2.3 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product Portfolio
  12. 4.2.5 Johnson & Johnson (Janssen) Recent Developments
  13. 4.3 Pfizer Inc.
  14. 4.3.1 Pfizer Inc. Company Information
  15. 4.3.2 Pfizer Inc. Business Overview
  16. 4.3.3 Pfizer Inc. Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Pfizer Inc. Pediatric Preventable Vaccine Product Portfolio
  18. 4.3.5 Pfizer Inc. Recent Developments
  19. 4.4 GlaxoSmithKline plc (GSK)
  20. 4.4.1 GlaxoSmithKline plc (GSK) Company Information
  21. 4.4.2 GlaxoSmithKline plc (GSK) Business Overview
  22. 4.4.3 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product Portfolio
  24. 4.4.5 GlaxoSmithKline plc (GSK) Recent Developments
  25. 4.5 Sinovac Biotech
  26. 4.5.1 Sinovac Biotech Company Information
  27. 4.5.2 Sinovac Biotech Business Overview
  28. 4.5.3 Sinovac Biotech Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sinovac Biotech Pediatric Preventable Vaccine Product Portfolio
  30. 4.5.5 Sinovac Biotech Recent Developments
  31. 4.6 Sinopharm Group Co.,
  32. 4.6.1 Sinopharm Group Co., Company Information
  33. 4.6.2 Sinopharm Group Co., Business Overview
  34. 4.6.3 Sinopharm Group Co., Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sinopharm Group Co., Pediatric Preventable Vaccine Product Portfolio
  36. 4.6.5 Sinopharm Group Co., Recent Developments
  37. 4.7 Serum Institute of India Pvt.
  38. 4.7.1 Serum Institute of India Pvt. Company Information
  39. 4.7.2 Serum Institute of India Pvt. Business Overview
  40. 4.7.3 Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Serum Institute of India Pvt. Pediatric Preventable Vaccine Product Portfolio
  42. 4.7.5 Serum Institute of India Pvt. Recent Developments
  43. 4.8 Novavax, Inc.
  44. 4.8.1 Novavax, Inc. Company Information
  45. 4.8.2 Novavax, Inc. Business Overview
  46. 4.8.3 Novavax, Inc. Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Novavax, Inc. Pediatric Preventable Vaccine Product Portfolio
  48. 4.8.5 Novavax, Inc. Recent Developments
  49. 4.9 Moderna, Inc.
  50. 4.9.1 Moderna, Inc. Company Information
  51. 4.9.2 Moderna, Inc. Business Overview
  52. 4.9.3 Moderna, Inc. Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Moderna, Inc. Pediatric Preventable Vaccine Product Portfolio
  54. 4.9.5 Moderna, Inc. Recent Developments
  55. 4.10 Merck & Co., Inc.
  56. 4.10.1 Merck & Co., Inc. Company Information
  57. 4.10.2 Merck & Co., Inc. Business Overview
  58. 4.10.3 Merck & Co., Inc. Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Merck & Co., Inc. Pediatric Preventable Vaccine Product Portfolio
  60. 4.10.5 Merck & Co., Inc. Recent Developments
  61. 4.11 Emergent BioSolutions Inc.
  62. 4.11.1 Emergent BioSolutions Inc. Company Information
  63. 4.11.2 Emergent BioSolutions Inc. Business Overview
  64. 4.11.3 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product Portfolio
  66. 4.11.5 Emergent BioSolutions Inc. Recent Developments
  67. 4.12 Daiichi Sankyo Company
  68. 4.12.1 Daiichi Sankyo Company Company Information
  69. 4.12.2 Daiichi Sankyo Company Business Overview
  70. 4.12.3 Daiichi Sankyo Company Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Daiichi Sankyo Company Pediatric Preventable Vaccine Product Portfolio
  72. 4.12.5 Daiichi Sankyo Company Recent Developments
  73. 4.13 CSL Limited (Seqirus)
  74. 4.13.1 CSL Limited (Seqirus) Company Information
  75. 4.13.2 CSL Limited (Seqirus) Business Overview
  76. 4.13.3 CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 CSL Limited (Seqirus) Pediatric Preventable Vaccine Product Portfolio
  78. 4.13.5 CSL Limited (Seqirus) Recent Developments
  79. 4.14 Bharat Biotech International
  80. 4.14.1 Bharat Biotech International Company Information
  81. 4.14.2 Bharat Biotech International Business Overview
  82. 4.14.3 Bharat Biotech International Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bharat Biotech International Pediatric Preventable Vaccine Product Portfolio
  84. 4.14.5 Bharat Biotech International Recent Developments
  85. 4.15 AstraZeneca plc
  86. 4.15.1 AstraZeneca plc Company Information
  87. 4.15.2 AstraZeneca plc Business Overview
  88. 4.15.3 AstraZeneca plc Pediatric Preventable Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 AstraZeneca plc Pediatric Preventable Vaccine Product Portfolio
  90. 4.15.5 AstraZeneca plc Recent Developments
5 Global Pediatric Preventable Vaccine Market Scenario by Region
  1. 5.1 Global Pediatric Preventable Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pediatric Preventable Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Pediatric Preventable Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Pediatric Preventable Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Pediatric Preventable Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Pediatric Preventable Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Pediatric Preventable Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Pediatric Preventable Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Pediatric Preventable Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pediatric Preventable Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Pediatric Preventable Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pediatric Preventable Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe Pediatric Preventable Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pediatric Preventable Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe Pediatric Preventable Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pediatric Preventable Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pediatric Preventable Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pediatric Preventable Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pediatric Preventable Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pediatric Preventable Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America Pediatric Preventable Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pediatric Preventable Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America Pediatric Preventable Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Pediatric Preventable Vaccine Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Pediatric Preventable Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pediatric Preventable Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Pediatric Preventable Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Pediatric Preventable Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pediatric Preventable Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Pediatric Preventable Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pediatric Preventable Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pediatric Preventable Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pediatric Preventable Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Pediatric Preventable Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Pediatric Preventable Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pediatric Preventable Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Pediatric Preventable Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pediatric Preventable Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pediatric Preventable Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pediatric Preventable Vaccine Value Chain Analysis
  2. 8.1.1 Pediatric Preventable Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pediatric Preventable Vaccine Production Mode & Process
  5. 8.2 Pediatric Preventable Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pediatric Preventable Vaccine Distributors
  8. 8.2.3 Pediatric Preventable Vaccine Customers
9 Global Pediatric Preventable Vaccine Analyzing Market Dynamics
  1. 9.1 Pediatric Preventable Vaccine Industry Trends
  2. 9.2 Pediatric Preventable Vaccine Industry Drivers
  3. 9.3 Pediatric Preventable Vaccine Industry Opportunities and Challenges
  4. 9.4 Pediatric Preventable Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst